Underdosing of thrombolytic drugs, subsequent encounter

This code indicates that a patient has received an insufficient amount of a thrombolytic medication, such as alteplase or tenecteplase, during a subsequent encounter for the condition being treated. This underdosing could lead to a lack of therapeutic effect, potentially worsening the patient's underlying thrombotic condition. It signifies that the patient is still under active treatment for the adverse effect of the underdosing.

Use this code when a patient presents for follow-up care related to a previous underdosing of a thrombolytic drug, and the underdosing is still impacting their treatment or condition. This would apply if the patient is experiencing ongoing symptoms, complications, or requires further intervention directly attributable to the insufficient medication administration. This code is appropriate for encounters after the initial treatment of the underdosing event.

• Always sequence this code after the code(s) for the specific condition being treated with the thrombolytic drug.
• Ensure documentation clearly states that the underdosing occurred and that the current encounter is for follow-up or ongoing management related to this event.
• Distinguish from initial encounters (A) or sequela (S) by verifying the "subsequent encounter" nature of the visit.